Medical devices, healthcare technology and the business of care
PMA approval · P170038

CentriMag Circulatory Support System

Abbott · Decision date Dec 6, 2019

FDA DECISIONP170038

What did the FDA approve?

FDA records P170038 as an original PMA application. The recorded decision is approval, dated Dec 6, 2019.

FDA approval order statement

Approval for temporary circulatory support for up to 30 days for one or both sides of the heart to treat postcardiotomy patients who fail to wean from cardiopulmonary bypass, providing a bridge to decision when it is unclear whether the patient's heart will recover or whether the patient will need alternative, longer-term therapy.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Dec 6, 2019

FDA source record

Regulatory record facts

Identifier
P170038
Regulatory pathway
Premarket approval application
Applicant
Abbott
Product code
DSQ
Decision code
APPR
Decision date
Dec 6, 2019
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Abbott
Product code
DSQ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P170038 received

    Application receipt date recorded by FDA.

  2. P170038 · FDA decision

    APPR

  3. P170038/S032 · Related supplement

    CentriMag Circulatory Support System

  4. P170038/S033 · Related supplement

    CentriMag Circulatory Support System

  5. P170038/S034 · Related supplement

    CentriMag Circulatory Support System

Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170038

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA supplementSep 2, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
AbbottPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records